Capstan Therapeutics to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Capstan Therapeutics to Participate in 45th Annual Goldman Sachs Global Healthcare Conference
The high-profile startup, co-founded by CAR-T innovator Carl June, will use the funds to bring an autoimmune disease treatment into proof-of-concept studies.
Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as CMO
Capstan Therapeutics Co-Founder Drew Weissman, M.D., Ph.D., Awarded Nobel Prize in Physiology or Medicine for Enabling Rapid Development of RNA-based COVID-19 Vaccine
Capstan Therapeutics to Participate in Upcoming Industry Conferences
Capstan Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO & PHILADELPHIA--(BUSINESS WIRE)--Capstan Therapeutics, Inc., a biotechnology company dedicated to developing and delivering precise in vivo cell engineering to patients, today announced the appointment of experienced biotechnology leader Athena Countouriotis, M.D., as Board Chair and Michael Rosenzweig, DVM, Ph.D., as Executive Vice President, Portfolio Strategy and Product Development.